Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by MyKnighton May 29, 2019 12:56pm
77 Views
Post# 29782056

RE:RE:RE:RE:RE:any price forecast price for this stock ?

RE:RE:RE:RE:RE:any price forecast price for this stock ?Glad you ask, that would be under 3 Billions $, buying price....

Wen you know that pharma can buy company easlily at this price....

The question the pharma is asking itself... how much I'm I going to make in 10 years...

RE:RE:RE:RE:any price forecast price for this stock ?

You do know the numbers of shares right ?? And what the mkt cap would be ??? At $5.95...SH dreaming here a lol No??


MyKnight wrote: Here's a brief history of Kaly for the last year and an half....

Last year in Feb Kaly(Rob) had an offer at 1.00$.... phase 1,. and we refuse it..., it was a canadian company that made that bid.... privilege info.

Now phase 2 getting finish by Sept/2019....

fast track on Phase 3.

This baby is getting sold before a year pass and my feeling, I said my felling is around 5.95$ ...

This being said, longer we wait better the price will be, we all know that the result are exceptional.

Number don't lie, I did my DD on this one for the last 2 year, and the story is coming to an end.


RE:RE:any price forecast price for this stock ?

Jack4000 wrote:
Hido64 wrote: any price forecast price for this stock ?????
Twenty to twenty five cents by August and then sell out at fifty in December.


assuming phase 2b is finalized by August? then licensed by December?

Read more at https://stockhouse.com/companies/bullboard?symbol=v.kly&postid=29780411#i7hqjRmCf0mXJZVQ.99

Read more at https://stockhouse.com/companies/bullboard?symbol=v.kly&postid=29781177#F6jkhDsijRzD05Q4.99
Bullboard Posts